ANI Pharmaceuticals vs Tarsier Pharma
ANI Pharmaceuticals vs Tarsier Pharma, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ANI Pharmaceuticals is on 49/100 and Tarsier Pharma on 47/100.
Where each one leads
ANI Pharmaceuticals
- agent readiness: 31/100 against 21/100
- domain rating: 56/100 against 33/100
- headcount: 707 against 12
- headcount growth: +95.8% against +2.8%
- funding raised: $671M against $5.0M
- LinkedIn following: 31,660 against 1,582
Tarsier Pharma
Leads on none of the measures we hold for both companies.
At a glance
| Measure | ANI Pharmaceuticals | Tarsier Pharma |
|---|---|---|
| What it is | Diversified biopharmaceutical company focused on rare diseases, generics, and established brands. | Clinical-stage company developing novel treatments for ocular inflammatory blinding diseases. |
| Category | Biotech, Pharmaceuticals, Rare Disease, Generics | Healthcare, Disease Treatment, Vision Impairment, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 1996 | 2016 |
| Headquarters | Baudette, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | ANI Pharmaceuticals | Tarsier Pharma |
|---|---|---|
| Employees | 707 | 12 |
| Headcount growthLast 12 months | +95.8% | +2.8% |
| Total funding | $671M | $5.0M |
| Latest round | Acquisition | Series B |
| LinkedIn followers | 31,660 | 1,582 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ANI Pharmaceuticals | Tarsier Pharma |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 47/100 |
| Traction | 60/100 | 45/100 |
| Team | 10/100 | 20/100 |
| Search visibility | 23/100 | 31/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (31/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 56/100 | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ANI Pharmaceuticals | Tarsier Pharma |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4 |
ANI Pharmaceuticals vs Tarsier Pharma: common questions
Which is better, ANI Pharmaceuticals or Tarsier Pharma?
On our 0-100 score ANI Pharmaceuticals rates higher (49/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do ANI Pharmaceuticals and Tarsier Pharma compare on the numbers?
ANI Pharmaceuticals leads on agent readiness (31/100 against 21/100), domain rating (56/100 against 33/100), headcount (707 against 12), headcount growth (+95.8% against +2.8%), funding raised ($671M against $5.0M), LinkedIn following (31,660 against 1,582).
Read the full ANI Pharmaceuticals review and pricing or the Tarsier Pharma review and pricing. You can also browse other ANI Pharmaceuticals alternatives we track.